IDenta(OTC) IDTA

IDenta Corp. operates as a detection and forensic science company, specializing in drug and explosives testing solutions. The company serves law enforcement, military, and government agencies globally, providing critical tools to combat illicit drugs and terrorist threats.

Products and Services

• Drug testing kits for various substances
• Explosives testing kits for security applications
• Forensic solutions including urine and saliva drug testing

Growth Outlook

• Expansion into international markets enhances revenue potential
• Increasing demand for drug testing solutions amid global drug crises
• Strategic partnerships with government agencies bolster market presence

Financial Highlights

• Recent quarterly revenue of $514,538 shows stable performance
• Trailing twelve months (TTM) net profit margin stands at 7.58%
• Current ratio of 4.32 indicates strong liquidity position

IDenta Corp. has demonstrated resilience in its financial performance, with a recent quarterly revenue of $514,538, reflecting consistent demand for its products. The trailing twelve months (TTM) data reveals a net profit margin of 7.58%, indicating effective cost management and operational efficiency. Furthermore, a current ratio of 4.32 suggests a robust liquidity position, allowing the company to meet short-term obligations comfortably. The growth outlook remains promising, driven by expanding international markets and increasing demand for drug testing solutions, positioning IDenta Corp. as a key player in the forensic science industry.